Safety and Immunogenicity of a Cluster Specific Immunotherapy in Children with Bronchial Asthma and Mite Allergy

Publisher： Karger

E-ISSN： 1423-0097|148|3|251-260

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.148, Iss.3, 2008-10, pp. : 251-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal duration of allergen immunotherapy in children with dust mite respiratory allergy

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 26, Iss. 1, 2015-02 ,pp. : 34-41

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive Factors for Clinical Response to Allergy Immunotherapy in Children with Asthma and Rhinitis

By  

International Archives of Allergy and Immunology, Vol. 164, Iss. 3, 2014-08 ,pp. : 210-217

Karger

Access to resources Recommend Favorite

Effect of Immunotherapy on the Production of Eosinophil Adhesion-Inducing Activity from Mononuclear Cells in House-Dust-Mite-Sensitive Bronchial Asthma

By  

International Archives of Allergy and Immunology, Vol. 117, Iss. 1, 1998-09 ,pp. : 20-23

Karger

Access to resources Recommend Favorite

Safety of Subcutaneous Specific Immunotherapy with Pollen Allergen Extracts for Respiratory Allergy

By  

International Archives of Allergy and Immunology, Vol. 132, Iss. 3, 2003-12 ,pp. : 258-262

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Low-Dose Oral Immunotherapy for Hen's Egg Allergy in Children

By  

International Archives of Allergy and Immunology, Vol. 171, Iss. 3-4, 2017-01 ,pp. : 265-268

Karger

Access to resources Recommend Favorite